Tivozanib combined with nivolumab: Phase Ib/II study in metastatic renal cell carcinoma (mRCC).

Escudier, B; Barthelemy, P; Ravaud, A; Negrier, S; Needle, MN; Albiges, L

JOURNAL OF CLINICAL ONCOLOGY, 2018; 36 (6):

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索